ImmunityBio (IBRX) Selling, General & Administrative (2014 - 2026)

ImmunityBio (IBRX) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 ImmunityBio 7.35 Bn 6.97 Bn 43.97 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Dec 31, 2025 -106.52 Mn
Sep 30, 2025 600,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 500,000.00
Dec 31, 2024 -122.52 Mn
Sep 30, 2024 35.92 Mn
Jun 30, 2024 675,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 -96.51 Mn
Sep 30, 2023 31.82 Mn
Jun 30, 2023 32.02 Mn
Mar 31, 2023 32.68 Mn
Dec 31, 2022 26.22 Mn
Sep 30, 2022 19.31 Mn
Jun 30, 2022 16.58 Mn
Mar 31, 2022 40.61 Mn
Dec 31, 2021 27.91 Mn
Sep 30, 2021 29.63 Mn
Jun 30, 2021 32.45 Mn